Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
This study has been completed.
Study NCT01563562
Information provided by Reata Pharmaceuticals, Inc.
First Received on March 23, 2012.
Last Updated on April 9, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
